SCHEMBL3134066

SCHEMBL3134066

CN(C)CCOC(=O)/C=C/C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 9/20 0.62
CHRM2 P08172 1/20 0.50
CHRM4 P08173 1/20 0.50
CHRM5 P08912 1/20 0.50
CHRM1 P11229 1/20 0.50
CHRNB2 P17787 1/20 0.50
CHRM3 P20309 1/20 0.50
CHRNA4 P43681 1/20 0.50
ATM Q13315 1/20 0.45
HRH1 P35367 2/20 0.43
ALDH1A1 P00352 1/20 0.41
DNM1 Q05193 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
PHLPP2 Q6ZVD8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5540490 1.00 HCAR2 (0.62) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL3134090 1.00 HCAR2 (0.62) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL4412330 0.92 CHRM2 (0.58) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL3134075 0.92 CHRM2 (0.58) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL5540497 0.92 CHRM2 (0.58) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL11679165 0.89 HCAR2 (0.55) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL11679173 0.89 HCAR2 (0.55) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL11680981 0.89 HCAR2 (0.55) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL11680988 0.89 HCAR2 (0.55) HCAR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL30356595 0.89 HCAR2 (0.65) HCAR2CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11377511-B2 Reducing agent monomer for preparing styrene-acrylic emulsion by oxidation-reduction reaction at room temperature, and synthesis method thereof Changzhou University (CN) 2022-07-05 US claimed
US-20220144986-A1 REDUCING AGENT MONOMER FOR PREPARING STYRENE-ACRYLIC EMULSION BY OXIDATION-REDUCTION REACTION AT ROOM TEMPERATURE, AND SYNTHESIS METHOD THEREOF Changzhou University (CN) 2022-05-12 US claimed
EP-2964827-B1 VENTILATION INSERT FREUDENBERG CARL KG (DE) 2019-11-06 EP claimed
CN-101648119-B Cation Gemini surfactant and preparation method thereof BENGBU BBCA MEDICINE SCIENCE DEV CO LTD 2011-08-10 CN claimed
CN-101648119-A Cation Gemini surfactant and preparation method thereof BENGBU BBCA MEDICINE SCIENCE D 2010-02-17 CN claimed
EP-1161565-B1 USE OF SUPERABSORBENT POLYMERS FOR TREATING RAW SKINS, CORRESPONDING COMPOSITIONS AND METHODS AND RESULTING TREATED SKINS SNF SA (FR) 2009-10-28 EP claimed
US-20250288972-A1 Nanoporous Superabsorbent Particles with Low Non-Solvent Levels KIMBERLY-CLARK WORLDWIDE, INC. 2025-09-18 US disclosed
US-12337297-B2 Nanoporous superabsorbent particles with low non-solvent levels KIMBERLY-CLARK WORLDWIDE, INC. (US) 2025-06-24 US disclosed
WO-2025129030-A1 PROCESS FOR PRODUCING ABSORBENT SUBSTRATES KIMBERLY-CLARK WORLDWIDE, INC. (US) 2025-06-19 WO disclosed
US-12194435-B2 Nanoporous superabsorbent particles KIMBERLY-CLARK WORLDWIDE, INC. (US) 2025-01-14 US disclosed
US-20250001395-A1 Microporous Superabsorbent Material KIMBERLY-CLARK WORLDWIDE, INC. 2025-01-02 US disclosed
US-20240375081-A1 Microporous Superabsorbent Material with Enhanced Surface Area KIMBERLY-CLARK WORLDWIDE, INC. 2024-11-14 US disclosed
CN-113004269-B Heterocyclic compounds of Kras-G12C inhibitors 首药控股(北京)股份有限公司 2024-11-05 CN disclosed
US-7396584-B2 Crosslinked polyamine coating on superabsorbent hydrogels BASF AKTIENGESELLSCHAFT (DE) 2008-07-08 US disclosed
EP-1922400-A1 DELIVERY SYSTEM FOR RELEASING SILICONE INGREDIENTS Dow Corning Corporation (US) 2008-05-21 EP disclosed
WO-2007028773-A1 DELIVERY SYSTEM FOR RELEASING SILICONE INGREDIENTS DOW CORNING CORPORATION (US) 2007-03-15 WO disclosed
US-6964745-B1 Use of superabsorbent polymers for treating raw skins, corresponding compositions and methods and resulting treated skins SNF S.A. (FR) 2005-11-15 US disclosed
US-6951911-B2 Cross-linked polymer and process for producing the same, absorptive structure and absorptive article SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-04 US disclosed
US-20030078349-A1 For use in paper diaper, a physiological napkin, a pad, a paper towel TAGAWA DAISUKE (JP) 2003-04-24 US disclosed
EP-1275669-A1 CROSSLINKED POLYMER, PROCESS FOR PRODUCING THE SAME, ABSORBENT STRUCTURE, AND ABSORBENT ARTICLE SANYO CHEMICAL INDUSTRIES, Ltd. (JP) 2003-01-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11377511-B2 Reducing agent monomer for preparing styrene-acrylic emulsion by oxidation-reduction reaction at room temperature, and synthesis method thereof SMS, DERA, ACMSD HCAR2 1141/4885CHRM2 4278/4885CHRM4 4340/4885
US-20220144986-A1 REDUCING AGENT MONOMER FOR PREPARING STYRENE-ACRYLIC EMULSION BY OXIDATION-REDUCTION REACTION AT ROOM TEMPERATURE, AND SYNTHESIS METHOD THEREOF SMS, DERA, ACMSD HCAR2 1141/4885CHRM2 4278/4885CHRM4 4340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.